20.05.2017

PJSC SIC “Borshchahivskiy CPP” could meet the requirements of the US market and monitor trends in the American pharmaceutical market while participating in the exhibition CPhI North America in Philadelphia (USA). The event brought together more than 7,500 participants.

 

40% of all medicines worldwide are sold in the US. A key factor in the sale of medicines in Europe is meeting Good Manufacturing Practices (GMP). In the USA the company must have a certificate from the Food and Drug Administration FDA.

 

For Ukrainian manufacturers that have already met GMP EU, it is easier to enter the US market.

 

BCPP introduced its own products to foreign specialists. There were, in particular, antibiotics and cardiological products made in accordance with the GMP.